References
- Pleis JR, Ward BW, Lucas JW. Summary health statistics for U.S. adults: National health interview survey, 2009. National Center for Health Statistics. Vital Health Stat.10(249), 1–207 (2010).
- US Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings NSDUH Series H-41 HHS Publication No. (SMA) 11–4658 (2011).
- McLellan AT, Lewis DC, O’Brian CP, Kleber H. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. J. Am. Med. Assoc.284(13), 1689–1695 (2000).
- Jorenby DE, Hays JT, Rigotti NA et al. Efficacy of varenicline, an a4b2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. J. Am. Med. Assoc.296, 56–63 (2006).
- Hatsukami DK, Jorenby D, Gonzales D et al. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin. Pharmacol. Ther.89(3), 392–399 (2011).
- Martell BA, Orson FM, Poling J et al. Cocaine vaccine for the treament of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Arch. Gen. Psychiat.66(10), 1116–1123 (2009).
- Carrera MR, Ashley JA, Wirsching P, Koob GF, Janda KD. A second-generation vaccine protects against the psychoactive effects of cocaine. Proc. Natl Acad. Sci.98, 1988–1992 (2001).
- Stowe GN, Vendruscolo LF, Edwards S et al. A vaccine strategy that induces protective immunity against heroin. J. Med. Chem.54(14), 5195–5204 (2011).
- Meijler MM, Matsushita H, Atobell LJ, Wirshing P, Janda KD. A new strategy for improved nicotine vaccines using conformationally constrained haptens. J. Am. Chem. Soc.125, 7164–7165 (2003).
- Moreno AY, Mayorov AV, Janda KD. Impact of distinct chemical structures for the development of a methamphetamine vaccine. J. Am. Chem. Soc.133(17), 6587–6595 (2011).
- Duryee MJ, Bevins RA, Reichel CM et al. Immune response to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines. Vaccine27, 2981–2988 (2009).
- Carroll FI, Blough BE, Pidaparthi RR et al. Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines. J. Med. Chem.54(14), 5221–5228 (2011).
Website
- GSK Corporate Press Release. October 2009. www.gsk.com/media/pressreleases/2009/2009_pressrelease_10112.htm